tradingkey.logo

Harvard Bioscience Inc

HBIO

0.435USD

-0.001-0.23%
Cierre 08/04, 16:00ETCotizaciones retrasadas 15 min
19.24MCap. mercado
PérdidaP/E TTM

Harvard Bioscience Inc

0.435

-0.001-0.23%
Más Datos de Harvard Bioscience Inc Compañía
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. The CMT product family is primarily composed of products supporting research related to molecular, cellular, organ and organoid technologies. The Preclinical product family includes products that support the preclinical research and testing phase for drug development, and in particular, testing related to data collection and analysis for safety and regulatory compliance.
Información de la empresa
Símbolo de cotizaciónHBIO
Nombre de la empresaHarvard Bioscience Inc
Fecha de salida a bolsaOct 21, 2013
Director ejecutivoMr. John D. Duke
Número de empleados330
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 21
Dirección84 October Hill Rd
CiudadHOLLISTON
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal01746-1371
Teléfono15088938999
Sitio Webhttps://www.harvardbioscience.com/
Símbolo de cotizaciónHBIO
Fecha de salida a bolsaOct 21, 2013
Director ejecutivoMr. John D. Duke
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
421.13K
+35.36%
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
87.29K
--
Robert Benson
Robert Benson
Independent Director
Independent Director
--
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
421.13K
+35.36%
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
87.29K
--
Robert Benson
Robert Benson
Independent Director
Independent Director
--
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Instruments, equipment, software and accessories
19.86M
91.23%
Service, maintenance and warranty contracts
1.91M
8.77%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
9.83M
45.13%
Europe, Middle East and Africa
6.03M
27.69%
China
2.73M
12.56%
Rest of Asia
2.35M
10.81%
Americas - Other
829.00K
3.81%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Instruments, equipment, software and accessories
19.86M
91.23%
Service, maintenance and warranty contracts
1.91M
8.77%
Estadísticas de accionistas
Actualizado: mar., 27 de may
Actualizado: mar., 27 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
AMH Equity, Ltd.
8.14%
Weber Capital Management, LLC
7.24%
BlackRock Institutional Trust Company, N.A.
5.75%
Harvey Partners, LLC
4.95%
The Vanguard Group, Inc.
4.84%
Other
69.08%
Accionistas
Accionistas
Proporción
AMH Equity, Ltd.
8.14%
Weber Capital Management, LLC
7.24%
BlackRock Institutional Trust Company, N.A.
5.75%
Harvey Partners, LLC
4.95%
The Vanguard Group, Inc.
4.84%
Other
69.08%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
25.50%
Investment Advisor
19.69%
Hedge Fund
17.14%
Individual Investor
8.96%
Venture Capital
7.24%
Pension Fund
2.27%
Research Firm
0.69%
Bank and Trust
0.11%
Family Office
0.07%
Other
18.33%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
212
35.78M
80.92%
-5.95M
2025Q1
216
35.57M
80.46%
-4.66M
2024Q4
216
39.38M
90.28%
+2.67M
2024Q3
217
37.20M
85.38%
-773.14K
2024Q2
216
36.12M
83.22%
-2.57M
2024Q1
216
36.60M
84.34%
-2.39M
2023Q4
219
36.53M
85.65%
-2.57M
2023Q3
223
36.90M
86.54%
-1.23M
2023Q2
223
36.47M
86.49%
-881.53K
2023Q1
220
35.48M
86.11%
-356.39K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
AMH Equity, Ltd.
3.60M
8.14%
-170.35K
-4.52%
May 29, 2025
Weber Capital Management, LLC
3.20M
7.24%
+683.45K
+27.15%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.54M
5.75%
-164.85K
-6.09%
Mar 31, 2025
Harvey Partners, LLC
2.19M
4.95%
-495.50K
-18.47%
Mar 31, 2025
The Vanguard Group, Inc.
2.14M
4.84%
-19.11K
-0.89%
Mar 31, 2025
Green (James W)
2.03M
4.59%
+348.61K
+20.74%
Mar 20, 2025
Royce Investment Partners
1.78M
4.02%
-187.22K
-9.53%
Mar 31, 2025
272 Capital LLC
1.56M
3.52%
+1.56M
--
Sep 30, 2024
Granahan Investment Management, LLC
1.53M
3.46%
-89.28K
-5.52%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.44M
3.25%
-227.31K
-13.65%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
Franklin US Small Cap Multifactor Index ETF
0%
iShares Micro-Cap ETF
0%
DFA Dimensional US Core Equity Market ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Small Cap Value ETF
0%
iShares Russell 2000 Growth ETF
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 Covered Call ETF
0%
WisdomTree US SmallCap Fund
0%
Ver más
Franklin US Small Cap Multifactor Index ETF
Proporción0%
iShares Micro-Cap ETF
Proporción0%
DFA Dimensional US Core Equity Market ETF
Proporción0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0%
Dimensional US Core Equity 1 ETF
Proporción0%
DFA Dimensional US Small Cap Value ETF
Proporción0%
iShares Russell 2000 Growth ETF
Proporción0%
ProShares Hedge Replication ETF
Proporción0%
Global X Russell 2000 Covered Call ETF
Proporción0%
WisdomTree US SmallCap Fund
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI